English | Español

Glaxosmithkline
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Carol Ostrow | Dec 16, 2017

Multiple myeloma study results encouraging, GSK says
Carol Ostrow | Dec 15, 2017

GSK receives FDA approval for expanded use of Nucala
Carol Ostrow | Dec 15, 2017

GSK says Shingrix promising for preventing shingles in stem cell transplant patients
Carol Ostrow | Sep 24, 2017

GlaxoSmithKline, Innoviva COPD therapy gains FDA approval
Carol Ostrow | Sep 23, 2017

Self-injectable form of Lupus therapy clears hurdle in Europe
Carol Ostrow | Sep 21, 2017

GSK’s Shingrix shingles vaccine clears an FDA hurdle

Carol Ostrow | Sep 18, 2017

Salford Lung Study shows promise for GlaxoSmithKline asthma treatment

Trending
Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects
Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment